Clinical Impact of Lesion Complexity on 2-Year Outcomes After Zotarolimus-Eluting Stents Implantation

[1]  M. Price,et al.  FINAL TWO-YEAR RESULTS FROM THE RANDOMIZED ONYX ONE TRIAL IN HIGH BLEEDING RISK PATIENTS TREATED WITH 1-MONTH DAPT , 2021 .

[2]  Hak Seung Lee,et al.  Relative Impact of Clinical Risk Versus Procedural Risk on Clinical Outcomes After Percutaneous Coronary Intervention. , 2021, Circulation. Cardiovascular interventions.

[3]  M. Price,et al.  One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk Patients , 2020, Circulation. Cardiovascular interventions.

[4]  V. Fuster,et al.  Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation , 2020, The Lancet.

[5]  A. Roguin,et al.  Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-Ultimaster registry. , 2020, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[6]  Samin K. Sharma,et al.  Ticagrelor With Aspirin or Alone After Complex PCI: The TWILIGHT-COMPLEX Analysis. , 2020, Journal of the American College of Cardiology.

[7]  M. Price,et al.  Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1 month of dual antiplatelet therapy. , 2019, American heart journal.

[8]  H. Daida,et al.  Clinical impact of complex percutaneous coronary intervention in patients with coronary artery disease , 2019, Cardiovascular Intervention and Therapeutics.

[9]  S. Achenbach,et al.  Comparison between treatment of “established” versus complex “off-label” coronary lesions with Absorb® bioresorbable scaffold implantation: results from the GABI-R® registry , 2019, Clinical Research in Cardiology.

[10]  P. Serruys,et al.  Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: two-year follow-up of the SYNTAX II study. , 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[11]  J. Chae,et al.  Effectiveness and Safety of Zotarolimus-Eluting Stent (Resolute™ Integrity) in Patients with Diffuse Long Coronary Artery Disease , 2019, Korean circulation journal.

[12]  G. Stone,et al.  Impact of percutaneous coronary intervention extent, complexity and platelet reactivity on outcomes after drug-eluting stent implantation. , 2018, International journal of cardiology.

[13]  I. Elgendy,et al.  Temporal Trends in Inpatient Use of Intravascular Imaging Among Patients Undergoing Percutaneous Coronary Intervention in the United States. , 2018, JACC. Cardiovascular interventions.

[14]  L. Räber,et al.  Current use of intracoronary imaging in interventional practice - Results of a European Association of Percutaneous Cardiovascular Interventions (EAPCI) and Japanese Association of Cardiovascular Interventions and Therapeutics (CVIT) Clinical Practice Survey. , 2018, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[15]  Rodrigo Modolo,et al.  SYNTAX II and SYNTAX III trials: what is the take home message for surgeons? , 2018, Annals of cardiothoracic surgery.

[16]  I. Palacios,et al.  Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention , 2016, Circulation.

[17]  Jeroen J. Bax,et al.  Third universal definition of myocardial infarction. , 2012, Global heart.

[18]  R. Virmani,et al.  Autopsy validation study of the academic research consortium stent thrombosis definition. , 2011, JACC. Cardiovascular interventions.

[19]  E. Hannan,et al.  Safety and Efficacy of Drug-Eluting and Bare Metal Stents: Comprehensive Meta-Analysis of Randomized Trials and Observational Studies , 2009, Circulation.